EODData

MEMBERSHIP REGISTER LOG IN

NYSE, ANRO: Alto Neuroscience Inc

04 Nov 25 15:59
LAST:

11.19

CHANGE:
 0.94		OPEN:
12.33		HIGH:
12.35		ASK:
0.00		VOLUME:
626.8K
CHG(%):
7.72		PREV:
12.17		LOW:
10.20		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Nov 2511.9811.9810.2011.23759.5K
03 Nov 2514.1914.2011.8112.17783.5K
31 Oct 2514.3114.7013.5314.19436.9K
30 Oct 2514.1015.1813.6714.32545.3K
29 Oct 2513.5215.0413.2314.041.21M
28 Oct 2512.1513.7211.7313.621.16M
27 Oct 2511.5012.7111.2312.251.03M
24 Oct 2511.6511.9510.9211.00356.5K
23 Oct 2510.2511.2410.1811.18437.5K
22 Oct 2510.5810.959.7310.20620.6K

COMPANY PROFILE

Name:Alto Neuroscience Inc
About:Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.
Sector:Healthcare
Industry:Biotechnology
Address:650 Castro Street, Mountain View, CA, United States, 94041
Website:https://www.altoneuroscience.com
CIK:0001999480
ISIN:US02157Q1094
FIGI:BBG00WYFS6R5

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-4.87 
Forward P/E:-4.94 
PEG Ratio:-0.58 
Price to Book:3.11 
Return on Assets:-0.25 
Return on Equity:-0.43 
EPS Ratio:-2.39 
Shares:27.08M 
Market Cap:302.99M 

TECHNICAL INDICATORS

MA5:13.1917.9%
MA10:12.4211.0%
MA20:9.6715.7%
MA50:6.3676.0%
MA100:4.59143.7%
MA200:3.72201.1%
STO9:5.50 
STO14:57.53
RSI14:68.66 
WPR14:-36.61
MTM14:5.35
ROC14:0.91 
ATR:1.71 
Week High:15.1835.7%
Week Low:10.209.7%
Month High:15.1835.7%
Month Low:5.23201.1%
Year High:15.1835.7%
Year Low:1.60599.4%
Volatility:81.64